InvestorsHub Logo

snayeman

11/13/21 1:59 PM

#384230 RE: frenchbroad #384229

Exactly, Leo would be mega mega wealthy if this trial was successful and he could position to retire soon if he chose too! But he now just keep working like a dog for his yearly salary!lucky him, makes zero sense

Hugon

11/13/21 2:55 PM

#384243 RE: frenchbroad #384229

Let’s see: each chapter per indication takes Ipix 3 years. Patent runway almost done.

sox040713

11/13/21 4:16 PM

#384261 RE: frenchbroad #384229

You believe B will be commercialized one day so Leo's shares will worth more than his salary. That I can understand. But what if you are Leo and know B will eventually fail. Don't you want to drag things out by running many mini-trials one at a time before the game is over?

You would think a CEO making half a million can walk and chew gum at the same time by running multiple trials. The stock cratered 80% because there's nothing in the pipeline that can generate revenue or partnership in years.

Some people said B-COVID failed because it targeted the wrong population. Those are the same people who praised how brilliant Dr. DeGrado is. I hope they see the irony. Good luck relying on who you think are "experts" here.

Anyone who thinks Mr. Ehrlich is more worried about his salary than the value of his shares is no expert for me.